Publications by authors named "Brian Sworder"

Claim this Profile
R
Remission Assessment by Circulating Tumor DNA in Large B-Cell Lymphoma.
Mark Roschewski, David M Kurtz, Jason R Westin, Ryan C Lynch, Ajay K Gopal, Brian J Sworder

J Clin Oncol· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The role of MRD monitoring and options for CLL management in relapsed/refractory disease.
Brian Sworder, Tanya Siddiqi

Hematology Am Soc Hematol Educ Program· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Immunotherapy in Chronic Lymphocytic Leukemia.
Brian Sworder, Tanya Siddiqi

Hematol Oncol Clin North Am· October 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A pharmacokinetic/pharmacodynamic model predicts tumor debulking improves CAR T-cell efficacy in Large B-Cell Lymphoma.
Amy E Pomeroy, Brian J Sworder, Deborah Plana, Yanguang Cao, Ash A Alizadeh

Blood Cancer Discov· October 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
CAR19 therapy drives expansion of clonal hematopoiesis and associated cytopenias.
Mark P Hamilton, Nick Phillips, Troy Noordenbos, Jan Boegeholz, Takeshi Sugio, Brian J Sworder

Res Sq· October 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Multifaceted cfDNA profiling in mantle cell lymphoma.
Brian J Sworder, Alex F Herrera

Blood Adv· September 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Integrative genomic analysis of DLBCL identifies immune environments associated with bispecific antibody response.
Sravya Tumuluru, James K Godfrey, Alan Cooper, Jovian Yu, Xiufen Chen, Brian J Sworder

Blood· May 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
IKAROS levels are associated with antigen escape in CD19- and CD22-targeted therapies for B-cell malignancies.
Pablo Domizi, Jolanda Sarno, Astraea Jager, Milton Merchant, Kaithlen Zen B Pacheco, Brian J Sworder

Nat Commun· April 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Deciphering response dynamics and treatment resistance from circulating tumor DNA after CAR T-cells in multiple myeloma.
Hitomi Hosoya, Mia Carleton, Kailee Tanaka, Brian Sworder, Shriya Syal

Nat Commun· February 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
CAR19 monitoring by peripheral blood immunophenotyping reveals histology-specific expansion and toxicity.
Mark P Hamilton, Erin Craig, Cesar Gentille Sanchez, Alain Mina, John Tamaresis, Brian Sworder

Blood Adv· June 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Integrative genomic analysis identifies unique immune environments associated with immunotherapy response in diffuse large B cell lymphoma.
Sravya Tumuluru, James K Godfrey, Alan Cooper, Jovian Yu, Xiufen Chen, Brian J Sworder

bioRxiv· April 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A human lymphoma organoid model for evaluating and targeting the follicular lymphoma tumor immune microenvironment.
Jenna M Kastenschmidt, Joseph G Schroers-Martin, Brian J Sworder, Suhas Sureshchandra, Michael S Khodadoust

Cell Stem Cell· March 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Specificity of immunoglobulin high-throughput sequencing minimal residual disease monitoring in non-Hodgkin lymphomas.
Navika D Shukla, Joseph G Schroers-Martin, Brian J Sworder, Karan Raj Kathuria, Stefan K Alig

Blood Adv· February 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Distinct Hodgkin lymphoma subtypes defined by noninvasive genomic profiling.
Stefan K Alig, Mohammad Shahrokh Esfahani, Andrea Garofalo, Michael Yu Li, Cédric Rossi, Brian J Sworder

Nature· January 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cell-free DNA in large B-cell lymphoma: MRD and beyond.
Brian J Sworder, David M Kurtz

Semin Hematol· July 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Tracing Founder Mutations in Circulating and Tissue-Resident Follicular Lymphoma Precursors.
Joseph G Schroers-Martin, Joanne Soo, Gabriel Brisou, Florian Scherer, David M Kurtz, Brian J Sworder

Cancer Discov· June 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Determinants of resistance to engineered T cell therapies targeting CD19 in large B cell lymphomas.
Brian J Sworder, David M Kurtz, Stefan K Alig, Matthew J Frank, Navika Shukla

Cancer Cell· January 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Inferring gene expression from cell-free DNA fragmentation profiles.
Mohammad Shahrokh Esfahani, Emily G Hamilton, Mahya Mehrmohamadi, Barzin Y Nabet, Stefan K Alig, Brian J Sworder

Nat Biotechnol· April 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Enhanced detection of minimal residual disease by targeted sequencing of phased variants in circulating tumor DNA.
David M Kurtz, Joanne Soo, Lyron Co Ting Keh, Stefan Alig, Jacob J Chabon, Brian J Sworder

Nat Biotechnol· December 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Secreted frizzled related-protein 2 (Sfrp2) deficiency decreases adult skeletal stem cell function in mice.
Luis Fernandez de Castro, Brian J Sworder, Byron Mui, Kathryn Futrega, Agnes Berendsen

Bone Res· December 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The landscape of tumor cell states and ecosystems in diffuse large B cell lymphoma.
Chloé B Steen, Bogdan A Luca, Mohammad S Esfahani, Armon Azizi, Brian J Sworder

Cancer Cell· October 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Short Diagnosis-to-Treatment Interval Is Associated With Higher Circulating Tumor DNA Levels in Diffuse Large B-Cell Lymphoma.
Stefan Alig, Charles W Macaulay, David M Kurtz, Ulrich Dührsen, Andreas Hüttmann, Brian J Sworder

J Clin Oncol· August 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Predicting HLA class II antigen presentation through integrated deep learning.
Binbin Chen, Michael S Khodadoust, Niclas Olsson, Lisa E Wagar, Ethan Fast, Brian J Sworder

Nat Biotechnol· November 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
B-cell lymphomas present immunoglobulin neoantigens.
Michael S Khodadoust, Niclas Olsson, Binbin Chen, Brian Sworder, Tanaya Shree

Blood· February 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Clinical presentation and treatment responses in IgM-related AL amyloidosis.
Moussa Sissoko, Vaishali Sanchorawala, David Seldin, Brian Sworder, Kenneth Angelino

Amyloid· October 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis